At RANZCO Scientific Congress in Perth Dr Amy Cohn explained the natural history of geographic atrophy (GA) and how it progresses. Describing GA as a “relentless, progressive disease” she said it impacts how patients see and experience the world. With a new treatment – pegcetacoplan injection (Apellis) – awaiting approval from the Therapeutics Goods Administration, it is essential to hone in on faster progressing patients who will become the first candidates. Here Dr Cohn explains how to identify them.
